Your session is about to expire
← Back to Search
Behavioural Intervention
Smartphone-Based Smoking Cessation Interventions for Smoking Cessation (Smart-TR01 Trial)
Phase 2 & 3
Waitlist Available
Led By Michael S Businelle, PhD
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 27 weeks
Awards & highlights
Smart-TR01 Trial Summary
This trial will compare the effectiveness of two smartphone apps for smoking cessation among low socioeconomic status adults.
Smart-TR01 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 27 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~27 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Biochemically-Verified Smoking Cessation
Secondary outcome measures
Change in cessation motivation
Change in cigarette availability
Change in smoking urge
+1 moreSmart-TR01 Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Smart-T + NRTExperimental Treatment1 Intervention
Smart-T provides content during the pre-quit and post-quit periods to prepare and support participants during their quit attempt. The Smart-T app contains multiple components including an EMA delivery and data transfer system, automated messages based upon EMA responses, and on-demand content. All participants will receive free nicotine replacement therapy (NRT).
Group II: NCI QuitGuide + NRTActive Control1 Intervention
The National Cancer Institute's QuitGuide app is a free smartphone app and is one of few apps that includes many of the recommendations detailed in the Clinical Practice Guideline. The QuitGuide app aims to help smokers understand their smoking patterns and develop the skills needed to quit smoking. QuitGuide provides content during the pre-quit and post-quit periods to prepare and support participants during their quit attempt. All participants will receive free nicotine replacement therapy (NRT).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Smart-T + NRT
2019
Completed Phase 3
~460
Find a Location
Who is running the clinical trial?
University of OklahomaLead Sponsor
455 Previous Clinical Trials
97,157 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,932,700 Total Patients Enrolled
Michael S Businelle, PhDPrincipal InvestigatorUniversity of Oklahoma
1 Previous Clinical Trials
500 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are willing to stop smoking one week after your first visit.You smoke at least 5 cigarettes every day.
Research Study Groups:
This trial has the following groups:- Group 1: Smart-T + NRT
- Group 2: NCI QuitGuide + NRT
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any current openings for patients who would like to enroll in this clinical trial?
"Per clinicaltrials.gov, this trial is still looking for eligible patients. The listing was first created on August 26th, 2019 and was last updated on December 10th, 2021."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger